SENSEONICS HOLDINGS INC (SENS)
US81727U1051 - Common Stock
We assign a fundamental rating of 2 out of 10 to SENS. SENS was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While SENS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, SENS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SENS has reported negative net income.
SENS had a negative operating cash flow in the past year.
In the past 5 years SENS reported 4 times negative net income.
SENS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
SENS's Return On Assets of -58.21% is on the low side compared to the rest of the industry. SENS is outperformed by 72.73% of its industry peers.
SENS has a worse Return On Equity (-109.54%) than 68.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -58.21% | ||
| ROE | -109.54% | ||
| ROIC | N/A |
ROA(3y)-38.59%
ROA(5y)-138.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SENS has a worse Gross Margin (12.04%) than 82.89% of its industry peers.
The Profit Margin and Operating Margin are not available for SENS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SENS has been increased compared to 1 year ago.
Compared to 5 years ago, SENS has more shares outstanding
The debt/assets ratio for SENS has been reduced compared to a year ago.
2.2 Solvency
SENS has an Altman-Z score of -7.67. This is a bad value and indicates that SENS is not financially healthy and even has some risk of bankruptcy.
SENS has a Altman-Z score of -7.67. This is in the lower half of the industry: SENS underperforms 75.94% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that SENS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.56, SENS is not doing good in the industry: 66.31% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.67 |
ROIC/WACCN/A
WACC8.82%
2.3 Liquidity
SENS has a Current Ratio of 7.53. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SENS (7.53) is better than 86.10% of its industry peers.
A Quick Ratio of 7.03 indicates that SENS has no problem at all paying its short term obligations.
SENS has a better Quick ratio (7.03) than 88.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.53 | ||
| Quick Ratio | 7.03 |
3. Growth
3.1 Past
The earnings per share for SENS have decreased strongly by -30.00% in the last year.
SENS shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.62%.
SENS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.43% yearly.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)36.62%
Revenue growth 3Y65.39%
Revenue growth 5Y3.43%
Sales Q2Q%-30.13%
3.2 Future
SENS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.42% yearly.
The Revenue is expected to grow by 29.59% on average over the next years. This is a very strong growth
EPS Next Y9.56%
EPS Next 2Y8.06%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue Next Year1.64%
Revenue Next 2Y28.01%
Revenue Next 3Y29.59%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SENS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.06%
EPS Next 3Y4.42%
5. Dividend
5.1 Amount
No dividends for SENS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SENSEONICS HOLDINGS INC
NYSEARCA:SENS (11/21/2024, 8:04:00 PM)
After market: 0.3152 -0.01 (-2.32%)0.3227
+0.01 (+1.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap191.24M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -58.21% | ||
| ROE | -109.54% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12.04% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.53 | ||
| Quick Ratio | 7.03 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y9.56%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)36.62%
Revenue growth 3Y65.39%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y